Evidence map›Paper›PMID 36389734›Full record

ArticleFrontiers in immunology2022

IL-2 availability regulates the tissue specific phenotype of murine intra-hepatic Tregs.

Ada S Kurt, Karoline Strobl, Paula Ruiz, Gabriel Osborn, Tonika Chester, Lauren Dawson, Karsten M Warwas, Elizabeth H Grey, Sotiris Mastoridis, Elisavet Kodela and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Ada S KurtInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Karoline StroblInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Paula RuizInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Gabriel OsbornInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Tonika ChesterInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Lauren DawsonInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Karsten M WarwasInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Elizabeth H GreyInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Sotiris MastoridisInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Elisavet KodelaInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Niloufar SafiniaInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Alberto Sanchez-FueyoInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
Marc Martinez-LlordellaInstitute of Liver Studies, Division of Transplantation Immunology & Mucosal Biology, King's College London, London, United Kingdom.
King's College London · GBNuffield Orthopaedic Centre · GB

Funding

Medical Research Council G1002000Medical Research Council MC_PC_19041Wellcome Trust 211113/Z/18/Z
6 · The paper itself

Abstract

CD4+CD25+Foxp3+ Tregs are known to acquire tissue-specific features and exert cytoprotective and regenerative functions. The extent to which this applies to liver-resident Tregs is unknown. In this study, we aimed to explore the phenotypic and functional characteristics of adult murine liver resident Tregs during homeostasis. Additionally, we investigated their role in ameliorating liver inflammation and tissue damage. Quantification of Foxp3+CD4+CD25+ cells comparing different tissues showed that the liver contained significantly fewer resident Tregs. A combination of flow cytometry phenotyping and microarray analysis of intra-hepatic and splenic Tregs under homeostatic conditions revealed that, although intra-hepatic Tregs exhibited the core transcriptional Treg signature, they expressed a distinct transcriptional profile. This was characterized by reduced CD25 expression and increased levels of pro-inflammatory Th1 transcripts

Indexed as

Forkhead Transcription FactorsHepatitisAnimalsInterleukin-2MiceMice, Inbred C57BLPhenotypeT-Lymphocytes, RegulatoryForkhead Transcription FactorsInterleukin-2acute inflammationCCl₄ induced liver injuryliverregulatory T cells (Tregs)tissue specificTreg depletion

Identifiers

PMID36389734
PMCPMC9661520
OpenAlexW4307869718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.